Comprehensive Income (Loss), Net of Tax, Attributable to Parent of ALTEROLA BIOTECH INC. from 31 Dec 2022 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
ALTEROLA BIOTECH INC. quarterly and annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD history and change rate from 31 Dec 2022 to 30 Sep 2024.
  • ALTEROLA BIOTECH INC. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 30 Sep 2024 was $803,383, a 438% decline year-over-year.
  • ALTEROLA BIOTECH INC. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending 30 Sep 2024 was $3,190,566.
  • ALTEROLA BIOTECH INC. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $2,402,392, a 19% decline from 2022.
Source SEC data
View on sec.gov
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Change (%)

ALTEROLA BIOTECH INC. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $3,190,566 $803,383 -$654,012 -438% 01 Jul 2024 30 Sep 2024 10-Q 29 Nov 2024 2025 Q2
Q2 2024 $2,536,554 $658,978 -$134,162 -26% 01 Apr 2024 30 Jun 2024 10-Q/A 25 Nov 2024 2025 Q1
Q1 2024 $2,402,392 $291,767 01 Jan 2024 31 Mar 2024 10-K 18 Jul 2024 2024 FY
Q4 2023 $2,019,972 -$1,510,913 -297% 01 Oct 2023 31 Dec 2023 10-Q/A 21 Feb 2024 2024 Q3
Q3 2023 $149,371 01 Jul 2023 30 Sep 2023 10-Q 29 Nov 2024 2025 Q2
Q2 2023 $524,816 01 Apr 2023 30 Jun 2023 10-Q/A 25 Nov 2024 2025 Q1
Q4 2022 $509,059 01 Oct 2022 31 Dec 2022 10-Q/A 21 Feb 2024 2024 Q3

ALTEROLA BIOTECH INC. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $2,402,392 -$384,480 -19% 01 Apr 2023 31 Mar 2024 10-K 18 Jul 2024 2024 FY
2022 $2,017,912 01 Apr 2022 31 Mar 2023 10-K 18 Jul 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.